Children aged 3-17 in UAE can now receive the Sinopharm Covid-19 vaccine
Now Reading
Children aged 3-17 in UAE can now receive the Sinopharm Covid-19 vaccine

Children aged 3-17 in UAE can now receive the Sinopharm Covid-19 vaccine

The decision comes in the wake of clinical trials and evaluations conducted in the country

The UAE’s Ministry of Health and Prevention (MoHAP) has announced the provision of the Sinopharm Covid-19 vaccine for children and adolescents between the ages of 3-17.

The National Emergency Crisis and Disaster Management Authority (NCEMA) took to Twitter on Monday, August 2, to announce that the decision comes in the wake of clinical trials and evaluations in the country, and is based on the emergency use authorisation and local assessments in line with regulations.

The UAE’s health ministry announced in June that it had initiated a Sinopharm immune bridge study for children aged 3 to 17, making it the first country in the Middle East and North Africa region to conduct a study of the vaccine’s effectiveness for this age group.

Read: UAE initiates Sinopharm vaccine study for children aged 3-17

The Department of Health – Abu Dhabi concluded the study for the vaccination stage and continues to monitor the immune response to the inoculation. The study examined a sample size of 900 children of different nationalities who met the eligibility requirements, Abu Dhabi Government Media office said.

In May, officials from the health ministry also approved the emergency use of the Pfizer-BioNTech Covid-19 vaccine for children between the ages of 12 to 15.

Read: Children between the age of 12-15 in the UAE now eligible for Pfizer-BioNTech Covid-19 vaccine

A total of 70.57 per cent of the UAE population is totally vaccinated against the Covid-19 contagion, while 78.95 per cent have received a single dose.

You might also like

© 2021 MOTIVATE MEDIA GROUP. ALL RIGHTS RESERVED.

Scroll To Top